Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Efficacy of a Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder

NCT05550493 is registered in ClinicalTrials.gov with Adai Technology (Beijing) Co., Ltd. as lead sponsor.

NCT NCT05550493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05550493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Efficacy of a Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
Lead sponsor
Adai Technology (Beijing) Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
May 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse